medigraphic.com
ISSN 1561-2937 (Print)

2017, Number 4

Next >>

Rev Cubana Cardiol Cir Cardiovasc 2017; 23 (4)

Nuclear magnetic resonance in the field of a new multimodal approach in Cardiology

Peix GA

Language: Spanish
References: 19
Page:
PDF size: 308.63 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Herzog BA, Greenwood JP, Plein S. Cardiovascular magnetic resonance. Physics for clinicians. Pocket guide. ESC 2015. Disponible en: www.cmr-guide.com.

  2. Valbuena-López S, Hinojar R, Puntmann V. Resonancia magnética cardiovascular en la práctica cardiológica: una guía concisa para la adquisición de imágenes y la interpretación clínica. Rev Esp Cardiol. 2016;69:202–10.

  3. Grothues F, Smith GC, Moon JC, Bellenger NG, Collins P, Klein HU, y cols. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol. 2002;90:29–34.

  4. Maceira AM, Prasad SK, Khan M, Pennell DJ. Reference right ventricular systolic and diastolic function normalized to age, gender and body surface area from steady-state free precession cardiovascular magnetic resonance. Eur Heart J. 2006;27:2879–88.

  5. Carrasco Muñoz S, Calles Blanco C, Marcin J, Fernández Álvarez C, Lafuente Martínez J. Contrastes basados en gadolinio utilizados en resonancia magnética. Radiología 2014;56(S1):21-8.

  6. Baritussio A, Scatteia A, Bucciarelli-Ducci C. Int J Cardiovasc Imaging (2017). https://doi.org/10.1007/s10554-017-1116-0.

  7. Assomull RG, Shakespeare C, Kalra PR, Lloyd G, Gulati A, Strange J. Role of cardiovascular magnetic resonance as a gatekeeper to invasive coronary angiography in patients presenting with heart failure of unknown etiology. Circulation 2011;124:1351–60.

  8. Hinojar R, Botnar R, Kaski JC, Prasad S, Nagel E, Puntmann VO. Individualized cardiovascular risk assessment by cardiovascular magnetic resonance. Future Cardiol 2014;10:273–89.

  9. Romero J, Xue X, Gonzalez W, Garcia MJ. CMR imaging assessing viability in patients with chronic ventricular dysfunction due to coronary artery disease: a meta-analysis of prospective trials. JACC Cardiovasc Imaging 2012;5:494–508.

  10. Kwong RY, Chan AK, Brown KA, Chan CW, Reynolds HG, Tsang S, y cols. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 2006;113:2733–43.

  11. Pennell DJ, Sechtem UP, Higgins CB, Manning WJ, Pohost GM, Rademakers FE, y cols. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Eur Heart J 2004;25:1940–65.

  12. Coelho-Filho OR, Seabra LF, Mongeon FP, Abdullah SM, Francis SA, Blankstein R, y cols. Stress myocardial perfusion imaging by CMR provides strong prognostic value to cardiac events regardless of patient’s sex. J Am Coll Cardiol Img 2011;4:850–61.

  13. Krittayaphong R, Chaithiraphan V, Maneesai A, Udompanturak S. Prognostic value of combined magnetic resonance myocardial perfusion imaging and late gadolinium enhancement. Int J Cardiovasc Imaging 2011;27:705–14.

  14. Abbasi SA, Heydari B, Shah RV, Murthy VL, Zhang YY, Blankstein R, y cols. Risk stratification by regadenoson stress magnetic resonance imaging in patients with known or suspected coronary artery disease. Am J Cardiol 2014;114:1198–203.

  15. Vincenti G, Masci PG, Monney P, Rutz T, Hugelshofer S, Gaxherri M, y cols. Stress perfusion CMR in patients with known and suspected CAD. Prognostic value and optimal ischemic threshold for revascularization. J Am Coll Cardiol Img 2017;10:526–37.

  16. Hachamovitch R, Rozanski A, Shaw LJ, Stone GW, Thomson LE, Friedman JD, y cols. Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy. Eur Heart J 2011;32:1012–24.

  17. Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, y cols. ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013;34:2949–3003.

  18. Hundley WG, Morgan TM, Neagle CM, Hamilton CA, Rerkpattanapipat P, Link KM. Magnetic resonance imaging determination of cardiac prognosis. Circulation 2002;106:2328–33.

  19. Giusca S, Kelle S, Nagel E, Buss SJ, Puntmann V, Wellnhofer E, y cols. Ischemic burden and clinical outcome: is one ‘culprit’ ischemic segment by dobutamine stress magnetic resonance predictive? PLoS ONE 2014;9:e115182.




2020     |     www.medigraphic.com